Showing results (111-120 of 167) with videos related to
Sort By:
Pageof 17
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 7, 2010
Phase III trial of bevacizumab plus interferon alfa versus interferon alfa monotherapy in patients with metastatic renal cell carcinoma: final results of CALGB 90206Brian I Rini, Susan Halabi, Jonathan E Rosenberg, et al.Cancer|April 15, 1990
A phase II trial of high-dose cytarabine and cisplatin in previously untreated non-small cell carcinoma of the lung. A Piedmont Oncology Association StudyD R White, B L Powell, J B Craig, et al.Cancer Chemotherapy and Pharmacology|January 1, 1987
Phase I study of high-dose cytosine arabinoside and etoposide in patients with advanced malignanciesB L Powell, H B Muss, R L Capizzi, et al.Cancer Genomics & Proteomics|June 7, 2013
Diagnostic microRNA markers to screen for sporadic human colon cancer in stool: I. Proof of principleFarid E Ahmed, Nancy C Ahmed, Paul W Vos, et al.Journal of the National Cancer Institute|December 9, 1997
Tamoxifen and chemotherapy for lymph node-negative, estrogen receptor-positive breast cancerB Fisher, J Dignam, N Wolmark, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 5, 2009
Treatment outcomes of different prognostic groups of patients on cancer and leukemia group B trial 39801: induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for unresectable stage III non-small cell lung cancerThomas E Stinchcombe, Lydia Hodgson, James E Herndon, et al.Journal of Neuro-Oncology|January 1, 1986
Clinical trial of pyridoxine to reduce vincristine neurotoxicityD V Jackson, E K Pope, R A McMahan, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 11, 2010
Consolidation therapy with subcutaneous alemtuzumab after fludarabine and rituximab induction therapy for previously untreated chronic lymphocytic leukemia: final analysis of CALGB 10101Thomas S Lin, Kathleen A Donohue, John C Byrd, et al.BJU International|November 6, 2009
Results of the Southwest Oncology Group phase II evaluation (study S0031) of ZD1839 for advanced transitional cell carcinoma of the urotheliumDaniel P Petrylak, Catherine M Tangen, Peter J Van Veldhuizen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1994
Tamoxifen versus high-dose oral medroxyprogesterone acetate as initial endocrine therapy for patients with metastatic breast cancer: a Piedmont Oncology Association studyH B Muss, L D Case, J N Atkins, et al.Pageof 17